Acadian Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,856
| Closed | -$230K | – | 1720 |
|
|
2024
Q4 | $230K | Sell |
22,856
-1,711
| -7% | -$17.2K | ﹤0.01% | 1239 |
|
|
2024
Q3 | $304K | Buy |
24,567
+11,622
| +90% | +$144K | ﹤0.01% | 1225 |
|
|
2024
Q2 | $167K | Buy |
+12,945
| New | +$167K | ﹤0.01% | 1460 |
|
|
2024
Q1 | – | Sell |
-18,337
| Closed | -$237K | – | 1683 |
|
|
2023
Q4 | $237K | Buy |
+18,337
| New | +$237K | ﹤0.01% | 1206 |
|
|
2023
Q3 | – | Sell |
-6,596
| Closed | -$177K | – | 1747 |
|
|
2023
Q2 | $177K | Buy |
+6,596
| New | +$177K | ﹤0.01% | 1296 |
|
|
2023
Q1 | – | Sell |
-56,383
| Closed | -$2.87M | – | 1854 |
|
|
2022
Q4 | $2.87M | Sell |
56,383
-322
| -0.6% | -$16.4K | 0.01% | 586 |
|
|
2022
Q3 | $4.64M | Buy |
56,705
+44,352
| +359% | +$3.63M | 0.03% | 417 |
|
|
2022
Q2 | $836K | Sell |
12,353
-20,908
| -63% | -$1.41M | ﹤0.01% | 852 |
|
|
2022
Q1 | $3.67M | Buy |
+33,261
| New | +$3.67M | 0.02% | 526 |
|
|
2019
Q2 | – | Sell |
-3,796
| Closed | -$333K | – | 1935 |
|
|
2019
Q1 | $333K | Buy |
+3,796
| New | +$333K | ﹤0.01% | 1220 |
|
|
2017
Q2 | – | Sell |
-272
| Closed | -$52K | – | 1515 |
|
|
2017
Q1 | $52K | Buy |
+272
| New | +$52K | ﹤0.01% | 1230 |
|